Our transgenic mouse data have demonstrated that overexpression of DcR3 in islets results in almost no insulitis and completely inhibits diabetes development without altering the diabetogenic properties of systemic lymphocytes, providing supportive evidence for the crucial role of the FasL-Fas pathway in β-cell damage. The gene discussed is FAS; the disease is diabetes mellitus.